Department of Ultrasound, Affiliated People's Hospital of Jiangsu University, Zhenjiang, China.
School of Medicine, Jiangsu University, Zhenjiang, China.
J Clin Ultrasound. 2022 Sep;50(7):942-950. doi: 10.1002/jcu.23260. Epub 2022 Jul 2.
The diffuse sclerosing variant of papillary thyroid carcinoma (DSV-PTC) has ultrasound findings that are similar to Hashimoto's thyroiditis (HT), resulting in under-diagnosis. DSV-PTC combined with HT is also common, so early and accurate diagnosis of DSV-PTC using a variety of diagnostic techniques, including FNAC, BRAF mutation detection, and ultrasound elastography, is critical.
To assess the diagnostic value of fine-needle aspiration cytology (FNAC) and BRAF detection in combination with ultrasound elastography in the diagnosis of DSV-PTC.
We performed a retrospective analysis of 40 patients with pathologically confirmed DSV-PTC and 43 patients with HT admitted to our hospital's ultrasound department between January 2015 and December 2020. Preoperative FNAC, BRAF mutation detection, and ultrasound elastography imaging were all performed on all patients. For a definitive diagnosis, the results of these tests were compared to postoperative pathological findings. The diagnostic value of FNAC, BRAF mutation detection, ultrasound elasticity imaging, and their combination for DSV-PTC diagnosis was assessed.
The mean elastic strain rate ratio (E1/E2) of the 40 DSV-PTC cases was 5.75 ± 2.14, while that of the 43 HT cases was 2.81 ± 1.20. The receiver operating characteristic (ROC) curve was generated using the average value of E2/E1. The area under the ROC curve was 0.910, and the optimal E2/E1 cut-off value was 4.500. When FNAC, BRAF mutation detection, and ultrasound elasticity imaging detection were combined, the diagnostic sensitivity, specificity, negative predictive value, positive predictive value, and accuracy of DSV-PTC diagnosis were 92.5%, 95.3%, 93.2%, 94.9%, and 94.0%, respectively, which were significantly higher than the single technique (p < 0.05).
The use of FNAC, BRAF mutation detection, and ultrasound elastography in combination is more helpful in establishing an accurate diagnosis of DSV-PTC than using a single diagnostic technique alone.
弥漫硬化型甲状腺乳头状癌(DSV-PTC)的超声表现与桥本甲状腺炎(HT)相似,导致诊断不足。DSV-PTC 合并 HT 也很常见,因此,使用细针穿刺细胞学检查(FNAC)、BRAF 突变检测和超声弹性成像等多种诊断技术对 DSV-PTC 进行早期、准确的诊断至关重要。
评估 FNAC 和 BRAF 检测联合超声弹性成像在 DSV-PTC 诊断中的诊断价值。
我们对 2015 年 1 月至 2020 年 12 月在我院超声科经病理证实的 40 例 DSV-PTC 患者和 43 例 HT 患者进行了回顾性分析。所有患者均行术前 FNAC、BRAF 突变检测和超声弹性成像检查。为明确诊断,将这些检查结果与术后病理结果进行比较。评估 FNAC、BRAF 突变检测、超声弹性成像及其联合诊断 DSV-PTC 的诊断价值。
40 例 DSV-PTC 患者的平均弹性应变率比(E1/E2)为 5.75±2.14,43 例 HT 患者的平均 E1/E2 为 2.81±1.20。使用 E2/E1 的平均值生成受试者工作特征(ROC)曲线。ROC 曲线下面积为 0.910,E2/E1 的最佳截断值为 4.500。当 FNAC、BRAF 突变检测和超声弹性成像检测联合使用时,DSV-PTC 诊断的灵敏度、特异度、阴性预测值、阳性预测值和准确度分别为 92.5%、95.3%、93.2%、94.9%和 94.0%,均明显高于单一技术(p<0.05)。
与单独使用单一诊断技术相比,FNAC、BRAF 突变检测和超声弹性成像联合使用更有助于准确诊断 DSV-PTC。